Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Tech Stocks That Meta Platforms Could Drag Lower

By Chris Lau, InvestorPlace Contributor

Tech stocks in the gaming sector may suffer from the spill-over of Meta Platform's wildly unpopular metaverse.

7 Tech Stocks to Buy at a Multi-Year Discount

By Chris Lau, InvestorPlace Contributor

Discounted tech stocks come only once every few years, so if readers hesitate now, they may miss out.

Hurry! 7 Pitiful Dow Stocks to Sell Before 2022 Ends.

By Chris Lau, InvestorPlace Contributor

The worsening economy will pressure all Dow stocks, but these seven should be among the top of the sell list for most investors right now.

7 Chinese Stocks Set to Soar From 52-Week Lows

By Chris Lau, InvestorPlace Contributor

President Xi Jinping’s power grab after the Chinese Party Congress spooked markets, creating a buying opportunity for Chinese stocks.

The 7 Biggest Cybersecurity Stocks Ranked From Best to Worst

By Chris Lau, InvestorPlace Contributor

Investors can get ahead by differentiating among the cybersecurity stocks with the highest growth potential, and avoiding the worst.

Load More